Skip to main content
Back to News
RISA Labs has secured 11.1 million dollars in Series A funding co-led by Cencora Ventures and Optum...
Funding
1 min read
US

RISA Labs has secured 11.1 million dollars in Series A funding co-led by Cencora Ventures and Optum...

The AMW Read

Updates the player map for oncology-focused Vertical AI (06) with a new entrant utilizing agentic workflows (02) to solve administrative bottlenecks.
NoveltySignificance
Healthcare & Bio Β· Player MapAI Agents Β· Definition

RISA Labs has secured 11.1 million dollars in Series A funding co-led by Cencora Ventures and Optum Ventures to scale its AI operating system for oncology. Its BOSS platform uses autonomous agents to manage complex workflows like prior authorizations across fragmented healthcare systems. By replacing manual paperwork with intelligent automation, the startup eliminates administrative bottlenecks that frequently delay life-saving treatments. This signifies a pivot toward AI agents that independently navigate payer ecosystems to optimize clinical operations. πŸš€

#HealthTech #AI #Oncology #VentureCapital #Innovation

How This Connects

Based on Healthcare & Bio Β· Player Map

  1. 1w agoAdaptyv raises €34.35M Series A for automated protein-design labAdaptyv
  2. 2w agoSkyLabs Sets September KOSDAQ Listing, Discloses $18.4M H1 2026 Revenue and Otsuka Distribution DealSkyLabs
  3. 2w agoVivodyne, a biotech startup spun out of the University of Pennsylvania in 2021, has unveiled HIVE, a...Vivodyne
  4. 7mo agoRISA Labs has secured 11.1 million dollars in Series A funding co-led by Cencora Ventures and Optum... Β· THIS ARTICLE

Related News

More news from Risa Labs Inc.

Stay updated with the latest news and announcements from Risa Labs Inc..

View all Risa Labs Inc. news

Discover AI Startups

Explore 5,000+ AI companies with VC-grade analysis, funding data, and investment insights.

Explore Dashboard